Published in Thorax on February 01, 2004
Airway immunopathology of asthma with exercise-induced bronchoconstriction. J Allergy Clin Immunol (2005) 1.12
Anti-Fas mAb-induced apoptosis and cytolysis of airway tissue eosinophils aggravates rather than resolves established inflammation. Respir Res (2005) 0.95
Bronchoalveolar lavage total cell count in interstitial lung diseases--does it matter? Inflammation (2012) 0.91
Effects of steroid treatment on lung CC chemokines, apoptosis and transepithelial cell clearance during development and resolution of allergic airway inflammation. Clin Exp Allergy (2006) 0.88
Polarized localization of epithelial CXCL11 in chronic obstructive pulmonary disease and mechanisms of T cell egression. J Immunol (2008) 0.85
Remodeling of extra-bronchial lung vasculature following allergic airway inflammation. Respir Res (2008) 0.85
Resolution of cell-mediated airways diseases. Respir Res (2010) 0.79
Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis. Respir Res (2010) 0.78
Maintained smoking cessation for 6 months equilibrates the percentage of sputum CD8+ lymphocyte cells with that of nonsmokers. Mediators Inflamm (2010) 0.78
Epithelial Rho GTPases and the transepithelial migration of lymphocytes. Methods Enzymol (2008) 0.77
Are healthy smokers really healthy? Tob Induc Dis (2016) 0.77
Resolution of leucocyte-mediated mucosal diseases. A novel in vivo paradigm for drug development. Br J Pharmacol (2012) 0.76
Pathogenesis of eosinophilic chronic rhinosinusitis. J Inflamm (Lond) (2016) 0.75
Broad Th2 neutralization and anti-inflammatory action of pentosan polysulfate sodium in experimental allergic rhinitis. Immun Inflamm Dis (2017) 0.75
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol (1992) 34.17
Mucosal inflammation in asthma. Am Rev Respir Dis (1990) 4.11
Mesothelin-family proteins and diagnosis of mesothelioma. Lancet (2003) 2.98
Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency. Nat Immunol (2002) 2.83
Anaphylaxis. N Engl J Med (1991) 2.53
Innate immunity and pulmonary host defense. Immunol Rev (2000) 2.48
The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol (1986) 2.29
Cell death mechanisms and the immune system. Immunol Rev (1991) 2.07
Apical secretion of a pathogen-elicited epithelial chemoattractant activity in response to surface colonization of intestinal epithelia by Salmonella typhimurium. J Immunol (1998) 2.06
Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med (1997) 1.91
Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest (2000) 1.85
Microarray analysis of eosinophils reveals a number of candidate survival and apoptosis genes. Am J Respir Cell Mol Biol (2001) 1.78
Inhibition of programmed eosinophil death: a key pathogenic event for eosinophilia? Immunol Today (1995) 1.66
Comparison of airway and blood eosinophil function after in vivo antigen challenge. J Immunol (1992) 1.63
Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol (1992) 1.56
Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy (1991) 1.52
Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood (1991) 1.51
Prompt epithelial damage and restitution processes in allergen challenged guinea-pig trachea in vivo. Clin Exp Allergy (1997) 1.46
In vivo restitution of airway epithelium. Cell Tissue Res (1995) 1.43
Orchestration of neutrophil movement by intestinal epithelial cells in response to Salmonella typhimurium can be uncoupled from bacterial internalization. Infect Immun (1999) 1.40
Epithelial permeability and the transepithelial migration of human neutrophils. J Cell Biol (1983) 1.28
New aspects of degranulation and fates of airway mucosal eosinophils. Am J Respir Crit Care Med (2000) 1.23
Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. Am J Respir Cell Mol Biol (1998) 1.21
Protein-tyrosine phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc Natl Acad Sci U S A (1994) 1.19
Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J Infect Dis (2000) 1.14
Eosinophils, neutrophils, and venular gaps in the airway mucosa at epithelial removal-restitution. Am J Respir Crit Care Med (1996) 1.13
Mitochondria in eosinophils: functional role in apoptosis but not respiration. Proc Natl Acad Sci U S A (2001) 1.12
Lung tissue eosinophils may be cleared through luminal entry rather than apoptosis: effects of steroid treatment. Am J Respir Crit Care Med (2001) 1.01
Eotaxin protein and gene expression in guinea-pig lungs: constitutive expression and upregulation after allergen challenge. Eur Respir J (1997) 1.01
Eosinophil lysis and free granules: an in vivo paradigm for cell activation and drug development. Trends Pharmacol Sci (1997) 0.96
Centennial notions of asthma as an eosinophilic, desquamative, exudative, and steroid-sensitive disease. Lancet (1997) 0.91
Allergen, bradykinin, and capsaicin increase outward but not inward macromolecular permeability of guinea-pig tracheobronchial mucosa. Clin Exp Allergy (1991) 0.90
Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5. J Allergy Clin Immunol (1996) 0.89
The migration of eosinophils into the sputum of asthmatics: the role of adhesion molecules. Clin Exp Allergy (1992) 0.87
A method for studies of tracheobronchial microvascular permeability to macromolecules. J Pharmacol Methods (1985) 0.85
Allergen-induced biphasic plasma exudation responses in guinea pig large airways. Am Rev Respir Dis (1993) 0.84
Neutrophil transepithelial migration is dependent upon epithelial characteristics. Am J Respir Cell Mol Biol (1996) 0.82
"Their's but to do and die": eosinophil longevity in asthma. J Allergy Clin Immunol (1999) 0.77
On the medical history of xanthines and other remedies for asthma: a tribute to HH Salter. Thorax (1985) 2.14
Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med (1997) 1.84
Beta-adrenoceptor mediated inhibition by terbutaline of histamine effects on vascular permeability. Br J Pharmacol (1978) 1.75
Xanthine derivatives as adenosine receptor antagonists. Eur J Pharmacol (1982) 1.62
Direct evidence of secondary necrosis of neutrophils during intense lung inflammation. Eur Respir J (2006) 1.62
Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. Eur Respir J (2001) 1.61
Effects of the cyclin-dependent kinase inhibitor R-roscovitine on eosinophil survival and clearance. Clin Exp Allergy (2011) 1.53
Capsaicin-induced cough in humans. Am Rev Respir Dis (1992) 1.49
Prompt epithelial damage and restitution processes in allergen challenged guinea-pig trachea in vivo. Clin Exp Allergy (1997) 1.46
In vivo restitution of airway epithelium. Cell Tissue Res (1995) 1.43
Pharmacological properties of 1-(3'5'-diisobutyryloxy-phenyl)-2-(t-butylamino)-ethanolhydrochloride (KWD 2058), a new sympathomimetic bronchodilator. Acta Pharmacol Toxicol (Copenh) (1974) 1.42
Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways. Clin Exp Allergy (1992) 1.42
The role of beta-receptor agonists in the inhibition of pulmonary edema. Ann N Y Acad Sci (1982) 1.40
Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med (1999) 1.34
Role of plasma exudation in asthmatic airways. Lancet (1986) 1.32
Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways. Am J Respir Crit Care Med (1999) 1.31
Cough and bronchoconstriction mediated by capsaicin-sensitive sensory neurons in the guinea-pig. Pulm Pharmacol (1988) 1.30
Influence of tracheal contraction on relaxant effects in vitro of theophylline and isoprenaline. Br J Pharmacol (1981) 1.27
New aspects of degranulation and fates of airway mucosal eosinophils. Am J Respir Crit Care Med (2000) 1.23
The use of the nose to study the inflammatory response of the respiratory tract. Thorax (1992) 1.22
Inflammatory passage of plasma macromolecules into airway wall and lumen. Pulm Pharmacol (1989) 1.22
Substance P antagonists and the role of tachykinins in non-cholinergic bronchoconstriction. Life Sci (1984) 1.16
The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy (1990) 1.15
Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol (1990) 1.14
Eosinophils, neutrophils, and venular gaps in the airway mucosa at epithelial removal-restitution. Am J Respir Crit Care Med (1996) 1.13
Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation. Br J Pharmacol (1985) 1.09
Airway opioid receptors mediate inhibition of cough and reflex bronchoconstriction in guinea pigs. J Pharmacol Exp Ther (1990) 1.09
Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease. Thorax (2001) 1.08
Differentiation of the contractile effects of prostaglandin E2 and the C-terminal octapeptide of cholecystokinin in isolated guinea-pig gallbladder. Acta Physiol Scand (1974) 1.07
Effect of seasonal allergic rhinitis on airway mucosal absorption of chromium-51 labelled EDTA. Thorax (1993) 1.05
Some pharmacological aspects of xanthines in asthma. Eur J Respir Dis Suppl (1980) 1.04
Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation. Am J Respir Cell Mol Biol (2001) 1.03
Airway epithelial repair: breathtakingly quick and multipotentially pathogenic. Thorax (1997) 1.03
Reversibility and reproducibility of histamine induced plasma leakage in nasal airways. Thorax (1989) 1.03
Enprofylline, a principally new antiasthmatic xanthine. Acta Pharmacol Toxicol (Copenh) (1981) 1.02
Lung tissue eosinophils may be cleared through luminal entry rather than apoptosis: effects of steroid treatment. Am J Respir Crit Care Med (2001) 1.01
Dual effects on the sphincter of Oddi and gallbladder induced by stimulation of the right great splanchnic nerve. Acta Physiol Scand (1973) 1.01
Long duration and high potency of antiexudative effects of formoterol in guinea-pig tracheobronchial airways. Am Rev Respir Dis (1991) 1.00
The epithelium and the pharmacology of guinea-pig tracheal tone in vitro. Br J Pharmacol (1988) 0.99
Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease. Eur J Clin Pharmacol (1982) 0.99
Inhibition of bradykinin induced macromolecular leakage from post-capillary venules by a beta2-adrenoreceptor stimulant, terbutaline. Acta Physiol Scand (1977) 0.99
Adenosine antagonism, a less desirable characteristic of xanthine asthma drugs? Acta Pharmacol Toxicol (Copenh) (1981) 0.99
Asymmetrical effects of increases in hydrostatic pressure on macromolecular movement across the airway mucosa. A study in guinea-pig tracheal tube preparations. Clin Exp Allergy (1991) 0.98
On the use of absorbing discs to sample mucosal surface liquids. Clin Exp Allergy (1990) 0.97
Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis. Allergy (1999) 0.96
Adrenoceptor functions in the cat choledochoduodenal junction in vitro. Br J Pharmacol (1971) 0.96
Leakage of macromolecules from guinea-pig tracheobronchial microcirculation. Effects of allergen, leukotrienes, tachykinins, and anti-asthma drugs. Acta Physiol Scand (1986) 0.96
The protective effects of intravenous theophylline and enprofylline against histamine- and adenosine 5'-monophosphate-provoked bronchoconstriction: implications for the mechanisms of action of xanthine derivatives in asthma. Pulm Pharmacol (1989) 0.96
The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. J Allergy Clin Immunol (1985) 0.96
Airway hyperreactivity and microvascular permeability to large molecules. Eur J Respir Dis Suppl (1983) 0.95
Development of safer xanthine drugs for treatment of obstructive airways disease. J Allergy Clin Immunol (1986) 0.95
Effects of enprofylline and theophylline may show the role of adenosine. Life Sci (1986) 0.94
Absorption of 51Cr EDTA across the human nasal airway barriers in the presence of topical histamine. Thorax (1991) 0.94
Pharmacologic control of plasma exudation into tracheobronchial airways. Am Rev Respir Dis (1991) 0.94
A novel bronchodilator xanthine apparently without adenosine receptor antagonism and tremorogenic effect. Eur J Respir Dis (1983) 0.94
Tachykinin antagonists have potent local anaesthetic actions. Eur J Pharmacol (1985) 0.94
The profile of action of enprofylline, or why adenosine antagonism seems less desirable with xanthine antiasthmatics. Agents Actions Suppl (1983) 0.93
Effect of morphine, cholecystokinin and sympathomimetics on the sphincter of Oddi and intramural pressure in cat duodenum. Scand J Gastroenterol (1972) 0.93
Adrenoceptors in the gall bladder. Acta Pharmacol Toxicol (Copenh) (1972) 0.93
Inhaled dsRNA and rhinovirus evoke neutrophilic exacerbation and lung expression of thymic stromal lymphopoietin in allergic mice with established experimental asthma. Allergy (2013) 0.93
Diagnostic and therapeutic aspects of urge urinary incontinence in women. Urol Int (1977) 0.93
Epithelial barrier formation by airway basal cells. Thorax (1997) 0.93
Adrenergic and Cholinergic Nerves of the Human Urethra and Urinary Bladder. A histochemical study. Acta Physiol Scand (1977) 0.92
Effects of prostaglandins on the isolated human bladder and urethra. Acta Physiol Scand (1977) 0.91
Effects of terbutaline on human uterine motility at term. Acta Obstet Gynecol Scand (1975) 0.91
Differentiation between bronchodilation and universal adenosine antagonism among xanthine derivatives. Life Sci (1982) 0.91
Increased sensitivity to toluene diisocyanate (TDI) in airways previously exposed to low doses of TDI. Clin Exp Allergy (1992) 0.91
Anti-asthma drugs attenuate inflammatory leakage of plasma into airway lumen. Acta Physiol Scand (1986) 0.91
Mucosal nitric oxide may tonically suppress airways plasma exudation. Am J Respir Crit Care Med (1994) 0.90
Elimination pathways of terbutaline. Eur J Respir Dis Suppl (1984) 0.90
Inflammatory leakage of macromolecules from the vascular compartment into the tracheal lumen. Acta Physiol Scand (1986) 0.90
Allergen, bradykinin, and capsaicin increase outward but not inward macromolecular permeability of guinea-pig tracheobronchial mucosa. Clin Exp Allergy (1991) 0.90
Effects of histamine, ethanol, and a detergent on exudation and absorption across guinea pig airway mucosa in vivo. Thorax (1991) 0.89
Enprofylline kinetics in healthy subjects after single doses. Clin Pharmacol Ther (1983) 0.89
Clearance of 99mTc DTPA from guinea pig nasal, tracheobronchial, and bronchoalveolar airways. Thorax (1990) 0.89
Increase in plasma free fatty acids and natriuresis by xanthines may reflect adenosine antagonism. Eur J Clin Pharmacol (1984) 0.89
Exudative hyperresponsiveness of the airway microcirculation in seasonal allergic rhinitis. Clin Exp Allergy (1995) 0.88
Terbutaline and adrenaline inhibit leakage of fluid and protein in guinea-pig lung. Eur J Pharmacol (1979) 0.88
Leakage of macromolecules from the tracheobronchial microcirculation. Am Rev Respir Dis (1987) 0.88
Evidence against vasoactive intestinal polypeptide (VIP) as a dilator and in favour of substance P as a constrictor in airway neurogenic responses. Br J Pharmacol (1983) 0.88
Overview of effects of theophylline. J Allergy Clin Immunol (1986) 0.88
Vascular anti-permeability effects of beta-receptor agonists and theophylline in the lung. Acta Pharmacol Toxicol (Copenh) (1979) 0.88
Bronchial exudation of bulk plasma at allergen challenge in allergic asthma. Am Rev Respir Dis (1992) 0.88
Interrelations between cyclic AMP, cyclic GMP and contraction in guinea pig gallbladder stimulated by cholecystokinin. Life Sci (1977) 0.87
Appearance of airway absorption and exudation tracers in guinea pig tracheobronchial lymph nodes. J Appl Physiol (1985) (1993) 0.87
Effects of formoterol on histamine induced plasma exudation in induced sputum from normal subjects. Thorax (1998) 0.87
Excitatory effect of tetrodotoxin on an isolated smooth muscle organ. J Pharm Pharmacol (1971) 0.87
Capsaicin-induced bronchoconstriction and neuropeptide release in guinea pig perfused lungs. J Appl Physiol (1985) (1990) 0.87
An in vitro comparison of beta-adrenoceptor stimulants on potassium-depolarized uterine preparations from guinea-pigs. Br J Pharmacol (1978) 0.87
Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season. Clin Exp Allergy (1991) 0.86
Plasma exudation and solute absorption across the airway mucosa. Clin Physiol (1993) 0.86
Mucosal exudation of fibrinogen in coronavirus-induced common colds. Acta Otolaryngol (1993) 0.86
Allergen challenge-induced acute exudation of IL-8, ECP and alpha2-macroglobulin in human rhinovirus-induced common colds. Eur Respir J (1999) 0.86
Tracheal relaxation from combinations of xanthines and of a beta 2-receptor agonist and xanthines. Lung (1986) 0.86
Tracheal relaxant and cardiostimulant actions of xanthines can be differentiated from diuretic and CNS-stimulant effects. Role of adenosine antagonism? Life Sci (1982) 0.86
Adrenoceptor and cholinoceptor mediated effects in the isolated urethra of cat and guinea-pig. Clin Exp Pharmacol Physiol (1976) 0.86
Allergen challenge-induced extravasation of plasma in mouse airways. Clin Exp Allergy (1998) 0.85
Relaxing effects of beta-receptor stimulators in isolated, gravid human myometrium. Life Sci (1973) 0.85
A method for studies of tracheobronchial microvascular permeability to macromolecules. J Pharmacol Methods (1985) 0.85
Effects on aggregation of human platelets of two xanthines and their interactions with adenosine. Acta Physiol Scand (1984) 0.85